Sandra Obikawa Kyosen

Sandra Obikawa Kyosen

Auto-generated profile, based on publicly available information

Sandra Obikawa Kyosen

Universidade Federal de Sao Paulo, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2015 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
NANouriya A. Al-Sannaa
Nouriya A. Al-Sannaa
LBLuisa Bay
Luisa Bay
DBDeborah S. Barbouth
Deborah S. Barbouth
YBYoussef Benhayoun
Youssef Benhayoun
CGCyril Goizet
Cyril Goizet
IHIva Ivanovska Holder
Iva Ivanovska Holder
Enzyme replacement therapy (ERT) with laronidase, (recombinant human α-L-iduronidase; Aldurazyme) is the primary treatment option for patients with attenuated mucopolysaccharidosis type I (MPS I). This study examined the effect of early ERT on clinical manifestations. This multinational, retrospective case series abstracted data from records of 20 patients with Hurler-Scheie syndrome within nine sibships that included older siblings treated with laronidase after the development of significant clinical symptoms, and younger siblings treated before significant symptomatology. Median age at diagnosis was 5.6 and 0.5 years for older and younger siblings, respectively. Median age at ERT initiation was 7.9 and 1.9 years for older and younger siblings, respectively. Improvement or stabilization of somatic signs and symptoms was more notable in younger siblings. Organomegaly present at onset of ERT improved in the majority of both older and younger siblings. Analysis of physician-rated symptom severity demonstrated that cardiac, musculoskeletal, and cognitive symptoms, when absent or mild in younger siblings at ERT initiation, generally did not develop or progress. The majority of older siblings had height/length Z-scores greater than two standard deviations below the mean (less than -2) at both time points. In general, Z-scores for younger siblings were closer to the sex- and age-matched means at follow-up. These findings suggest early initiation of laronidase, prior to the onset of symptoms in patients with attenuated MPS I, can slow or prevent the development of severe clinical manifestations.

1 May 2010 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
HKHiroshi Kobayashi
Hiroshi Kobayashi
YSYohta Shimada
Yohta Shimada
MIMasahiro Ikegami
Masahiro Ikegami
TKToshinao Kawai
Toshinao Kawai
KSKen Sakurai
Ken Sakurai
HIHiroyuki Ida
Hiroyuki Ida

11 February 2014
Verified
Book Chapter
Closed access
PDF file
CLChristina Lampe
Christina Lampe
AAAndrea Atherton
Andrea Atherton
BBBarbara K. Burton
Barbara K. Burton
MDMaria Descartes
Maria Descartes
RGRoberto Giugliani
Roberto Giugliani
LSLaurie D. Smith
Laurie D. Smith

1 October 2009 in The Journal of Pediatrics
Verified
Journal Article
Closed access
AMAna Maria Martins
Ana Maria Martins
VDVânia D'almeida
Vânia D'almeida
SKSandra Obikawa Kyosen
Sandra Obikawa Kyosen
ETEdna Tiemi Takata
Edna Tiemi Takata
ADAlvimar Gonçalves Delgado
Alvimar Gonçalves Delgado
RBRicardo Villela Bastos
Ricardo Villela Bastos

5 April 2014 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
GMGustavo A. Moreira
Gustavo A. Moreira
SKSandra O. Kyosen
Sandra O. Kyosen
CPCamilla L. Patti
Camilla L. Patti
AMAna Maria Martins
Ana Maria Martins
STSergio Tufik
Sergio Tufik

24 December 2009 in Gene Therapy
Verified
Journal Article
Closed access
PDF file
SKS O Kyosen
S O Kyosen
SIS Iizuka
S Iizuka
HKH Kobayashi
H Kobayashi
TKT Kimura
T Kimura
TFT Fukuda
T Fukuda
TOT Ohashi
T Ohashi